Annual Reports

The Melanoma Research Alliance has become the largest non-profit funder focused on melanoma. In addition to funding the best research possible, MRA also works to connect the dots between researchers, specialties, patients and families, and other stakeholders. Read our 2017 - 2018 report.

Through powerful research, the Melanoma Research Alliance (MRA) is quickly delivering results and saving lives. Over the past 10 years, MRA has invested $100 million - and leveraged an additional $90 million - to support 233 different research projects in 15 countries.

Featured in this report are some of our key achievements from the past year. These accomplishments highlight our capacity to partner with stakeholders and fund scientific studies that will accelerate transformative advances in melanoma research.

This report marks another groundbreaking year of progress for patients with melanoma. The approvals of new therapies, whether alone orin combination with others, underscore the tremendous advancements in treatment option.

The 2013-2014 Progress Report highlights the year's incredible achievements and advancements made on behalf of melanoma patients and our continued strategy to build upon innovative developments in the field.